Urochol (Drops) Instructions for Use
Marketing Authorization Holder
Vifitech, CJSC (Russia)
ATC Code
G04BC (Drugs for the treatment of nephrourolithiasis)
Dosage Form
| Urochol | Oral drops: dropper bottles or bottles 15 ml, 25 ml, or 50 ml |
Dosage Form, Packaging, and Composition
Oral drops as a liquid from greenish-brown to brown in color, with a characteristic odor.
| 100 ml | |
| Hop extract liquid | 32.995 g |
| Wild carrot fruit liquid extract | 23 g |
| Origanum extract liquid | 23 g |
| Castor oil | 11 g |
| Fir needle oil | 8 g |
| Peppermint oil | 2 g |
Excipients: disodium edetate (Trilon B) – 0.005 g.
15 ml – dark glass dropper bottles (1) – cardboard packs.
25 ml – dark glass dropper bottles (1) – cardboard packs.
50 ml – dark glass dropper bottles (1) – cardboard packs.
15 ml – dark glass bottles (1) – cardboard packs.
25 ml – dark glass bottles (1) – cardboard packs.
50 ml – dark glass bottles (1) – cardboard packs.
Clinical-Pharmacological Group
Herbal preparation with diuretic, choleretic, litholytic, and anti-inflammatory action
Pharmacotherapeutic Group
Spasmolytic agent of plant origin
Pharmacological Action
A combined herbal medicinal product. It has spasmolytic, anti-inflammatory, antiseptic action. It increases diuresis, acidifies urine, increases the excretion of urea and chloride ions, and enhances bile formation and bile secretion.
Indications
Nephrourolithiasis; cholelithiasis; pyelonephritis; cholecystitis; cholangiohepatitis; biliary dyskinesia.
As part of complex therapy: acute cystitis, nephrourolithiasis, cholelithiasis; pyelonephritis; cholecystitis; biliary dyskinesia.
ICD codes
| ICD-10 code | Indication |
| K80 | Cholelithiasis [cholelithiasis] (including biliary colic) |
| K81.0 | Acute cholecystitis |
| K81.1 | Chronic cholecystitis |
| K82.8 | Other specified diseases of gallbladder and cystic duct (including dyskinesia) |
| K83.0 | Cholangitis |
| N10 | Acute tubulointerstitial nephritis (acute pyelonephritis) |
| N11 | Chronic tubulointerstitial nephritis (chronic pyelonephritis) |
| N20 | Calculus of kidney and ureter |
| N21 | Calculus of lower urinary tract |
| ICD-11 code | Indication |
| DC11.Z | Cholelithiasis, unspecified |
| DC12.0Z | Acute cholecystitis, unspecified |
| DC12.1 | Chronic cholecystitis |
| DC13 | Cholangitis |
| DC1Z | Diseases of gallbladder and biliary tract, unspecified |
| DD94 | Functional disorder of the gallbladder |
| GB50 | Acute tubulo-interstitial nephritis |
| GB51 | Acute pyelonephritis |
| GB55.Z | Chronic tubulo-interstitial nephritis, unspecified |
| GB5Z | Renal tubulo-interstitial diseases, unspecified |
| GB70.Z | Calculus of upper urinary tract, unspecified |
| GB71.Z | Calculus of lower urinary tract, unspecified |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Administer the drops sublingually on a piece of sugar.
Take 8-10 drops three times daily before meals.
For renal colic or hepatic colic, increase the single dose to 15-20 drops.
Adhere to the prescribed course of treatment, which typically lasts from 5 days to 1 month depending on disease severity.
Do not use in patients under 18 years of age.
Be aware that the formulation contains ethanol.
Store the medication between 2°C and 15°C in its original packaging, protected from light.
Keep the bottle securely out of the reach of children.
Adverse Reactions
Nervous system disorders: dizziness, general weakness.
Gastrointestinal disorders: nausea, vomiting, diarrhea, abdominal pain.
Immune system disorders: allergic reactions (facial redness, skin rash, itching, angioedema).
Cardiovascular system disorders: increased blood pressure, decreased blood pressure.
Contraindications
Hypersensitivity to the components of the combination; heartburn; nausea, vomiting, diarrhea, diameter of gallstones more than 3 mm, pregnancy, breastfeeding period, age under 18 years.
With caution
Alcoholism, liver disease, traumatic brain injury, brain diseases, epilepsy.
Use in Pregnancy and Lactation
Contraindicated for use during pregnancy and breastfeeding.
Pediatric Use
Contraindicated for use in children under 18 years of age.
Special Precautions
The dosage form drops contain ethanol.
Storage Conditions
Store at 2°C (36°F) to 15°C (59°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer